Literature DB >> 11153738

Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation.

A R Patel1, J T Kuvin, N G Pandian, J J Smith, J E Udelson, M E Mendelsohn, M A Konstam, R H Karas.   

Abstract

OBJECTIVES: The goal of this study was to examine the effect of heart failure etiology on peripheral vascular endothelial function in cardiac transplant recipients.
BACKGROUND: Peripheral vascular endothelial dysfunction occurs in patients with heart failure of either ischemic or nonischemic etiology. The effect of heart failure etiology on peripheral endothelial function after cardiac transplantation is unknown.
METHODS: Using brachial artery ultrasound, endothelium-dependent, flow-mediated dilation (FMD) was assessed in patients with heart failure with either nonischemic cardiomyopathy (n = 10) or ischemic cardiomyopathy (n = 7), cardiac transplant recipients with prior nonischemic cardiomyopathy (n = 10) or prior ischemic cardiomyopathy (n = 10) and normal controls (n = 10).
RESULTS: Patients with heart failure with either ischemic cardiomyopathy or nonischemic cardiomyopathy had impaired FMD (3.6 +/- 1.0% and 5.1 +/- 1.2%, respectively, p = NS) compared with normal subjects (13.9 +/- 1.3%, p < 0.01 compared with either heart failure group). In transplant recipients with antecedent nonischemic cardiomyopathy, FMD was markedly higher than that of heart failure patients with nonischemic cardiomyopathy (13.0 +/- 2.4%, p < 0.001) and similar to that of normal subjects (p = NS). However, FMD remained impaired in transplant recipients with prior ischemic cardiomyopathy (5.5 +/- 1.5%, p = 0.001 compared with normal, p = 0.002 vs. transplant recipients with previous nonischemic cardiomyopathy).
CONCLUSIONS: Peripheral vascular endothelial function is normal in cardiac transplant recipients with antecedent nonischemic cardiomyopathy, but remains impaired in those with prior ischemic cardiomyopathy. In contrast, endothelial function is uniformly abnormal for patients with heart failure, regardless of etiology. These findings indicate that cardiac transplantation corrects peripheral endothelial function for patients without ischemic heart disease, but not in those with prior atherosclerotic coronary disease.

Entities:  

Mesh:

Year:  2001        PMID: 11153738     DOI: 10.1016/s0735-1097(00)01057-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).

Authors:  Jorge Silva Enciso; Tomoko S Kato; Zhezhen Jin; Christine Chung; Jonathan Yang; Hiroo Takayama; Donna M Mancini; P Christian Schulze
Journal:  Am J Cardiol       Date:  2014-07-17       Impact factor: 2.778

2.  Effects of the left ventricular assist device on the compliance and distensibility of the carotid artery.

Authors:  Danielle L Templeton; Ranjit John; Patricia Painter; Aaron S Kelly; Donald R Dengel
Journal:  Heart Vessels       Date:  2012-08-09       Impact factor: 2.037

3.  Endothelial function and soluble endoglin in smokers with heart failure.

Authors:  Kevin S Heffernan; Jeffrey T Kuvin; Ayan R Patel; Richard H Karas; Navin K Kapur
Journal:  Clin Cardiol       Date:  2011-11-28       Impact factor: 2.882

4.  Endothelial dysfunction and circadian blood pressure rhythmicity in young heart transplant recipients.

Authors:  David A Parra; D Scott Lim; Carolyn L Buller; John R Charpie
Journal:  Pediatr Cardiol       Date:  2007 Jan-Feb       Impact factor: 1.655

5.  Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond.

Authors:  Melissa A H Witman; Anette S Fjeldstad; John McDaniel; Stephen J Ives; Jia Zhao; Zachary Barrett-O'Keefe; Jose N Nativi; Josef Stehlik; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

6.  Study of endothelial function and vascular stiffness in patients affected by dilated cardiomyopathy on treatment with sacubitril/valsartan.

Authors:  Ludovica Amore; Fabio Alghisi; Edoardo Pancaldi; Greta Pascariello; Angelica Cersosimo; Giuliana Cimino; Nicola Bernardi; Emiliano Calvi; Carlo Mario Lombardi; Edoardo Sciatti; Enrico Vizzardi; Marco Metra
Journal:  Am J Cardiovasc Dis       Date:  2022-06-15

7.  Endothelial function evaluation in idiopathic vs. ischemic dilated cardiomyopathy.

Authors:  Edoardo Pancaldi; Chiara Tedino; Mauro Riccardi; Fabio Alghisi; Giuliana Cimino; Greta Pascariello; Emiliano Calvi; Edoardo Sciatti; Enrico Vizzardi; Marco Metra
Journal:  Am J Cardiovasc Dis       Date:  2022-06-15

Review 8.  Endothelial dysfunction and cardiac allograft vasculopathy.

Authors:  Monica Colvin-Adams; Nonyelum Harcourt; Daniel Duprez
Journal:  J Cardiovasc Transl Res       Date:  2012-11-08       Impact factor: 4.132

9.  Cocoa flavanols reduce N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure.

Authors:  Rodney De Palma; Imelda Sotto; Elizabeth G Wood; Noorafza Q Khan; Jane Butler; Atholl Johnston; Martin T Rothman; Roger Corder
Journal:  ESC Heart Fail       Date:  2015-12-08

Review 10.  Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review.

Authors:  Gary D Lopaschuk; Subodh Verma
Journal:  JACC Basic Transl Sci       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.